In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
glioblastoma
OMRF discovers compound that could fight deadly cancer
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
Biotech company acquires OMRF brain cancer drug
Agreement will expand clinical trials of glioblastoma drug
New OMRF vice president focuses on bringing discoveries to the world
Technology Ventures works to pair scientists with industry partners.
Biomarkers help doctors decide how to treat brain cancers
OMRF’s biomarker discoveries could bring new therapies for beating gliomas.